Who are Psyomics - company's investors?

Psyomics - company's investors include Cambridge Angels group, EMV Capital, Martlet Capital, University of Cambridge Enterprise.

Psyomics - company

4 known investors

Find your way into Psyomics - company

Paths you didn't know you had: your email and LinkedIn already hold routes to the Psyomics - company team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Psyomics builds behavioral health assessment tools, including beseen™, which captures structured data and free text from patients, families, and professionals to support clinical pathways for adults and young people. The company is also developing a dry blood spot biomarker test to distinguish Major Depressive Disorder from Bipolar disorder to reduce misdiagnosis.

Digital Health Healthtech Mental Health

Founders & leadership

Dr. Melinda Rees Chief Executive OfficerDr. Melinda Rees is a registered clinical psychologist with 25+ years of clinical leadership experience in the NHS, followed by a decade in strategic healthcare leadership roles in the independent sector. She is CEO of Psyomics, which develops behavioral health assessment tools and biomarker tests for mental health diagnosis.

Rupert Hipwell Chief Commercial OfficerRupert Hipwell is Chief Commercial Officer of Psyomics, where he leads strategy and operations. He has held senior management roles in healthcare and life sciences focused on corporate development, marketing, and sales, with experience launching and scaling ventures.

Alex Nancekievill Chief Technology OfficerAlex Nancekievill is Chief Technology Officer at Psyomics. He has 24 years of experience developing medical devices and software across biotech and healthcare, including leading product development at Asymptote (sold to GE Healthcare) and HBSUK (sold to AXA Health), where he worked on regulated medical device platforms, machine learning applications, and NHS Digital integrations.

Investors · 4

Cambridge Angels grouplisted by Cambridge Angels groupCambridge · $195K – $1.9M

How we know: Cambridge Angels group's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

EMV Capitallisted by EMV CapitalLondon

How we know: EMV Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Martlet Capitallisted by Martlet CapitalCambridge · $317.5K

How we know: Martlet Capital's portfolio page · Not right? Tell us

University of Cambridge EnterprisereportedCambridge

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Frequently asked questions

What does Psyomics - company do?: Psyomics builds behavioral health assessment tools, including beseen™, which captures structured data and free text from patients, families, and professionals to support clinical pathways for adults and young people. The company is also developing a dry blood spot biomarker test to distinguish Major Depressive Disorder from Bipolar disorder to reduce misdiagnosis.
Who are Psyomics - company's investors?: Psyomics - company's investors include Cambridge Angels group, EMV Capital, Martlet Capital, University of Cambridge Enterprise.